Literature DB >> 26338695

Moxibustion relieves visceral hyperalgesia via inhibition of transient receptor potential vanilloid 1 (TRPV1) and heat shock protein (HSP) 70 expression in rat bone marrow cells.

Weiying Zou1, Hua Lin2, Wenwen Liu1, Bei Yang1, Lei Wu1, Limin Duan3, Ping Ling3, Lingyan Zhu1, Qun Dai1, Lintong Zhao1, Ting Zou1, Dalei Zhang1.   

Abstract

OBJECTIVE: To investigate the effects of moxibustion on visceral hyperalgesia (VH) and bone marrow cell transient receptor potential vanilloid type 1 (TRPV1) and heat shock protein (HSP) 70 expression in a rat model of VH.
METHODS: Mechanical colorectal distension was performed to induce VH in neonatal Sprague-Dawley rats. Eight-week-old VH rats were treated with moxibustion at acupuncture point BL25 or an ipsilateral non-acupuncture point. Abdominal withdrawal reflex (AWR) scoring and pain threshold pressure assessment were performed before and after moxibustion treatment for 7 consecutive days. The expression of TRPV1 and HSP70 in bone marrow cells was quantified by real-time quantitative PCR.
RESULTS: The expression of TRPV1 and HSP70 in bone marrow cells was increased in rats with VH. Moxibustion at BL25 significantly decreased AWR scores and increased pain threshold pressure in rats with VH. Furthermore, moxibustion at BL25 significantly inhibited the VH-induced increase in the expression of TRPV1 and HSP70 in bone marrow cells.
CONCLUSIONS: The up-regulation of TRPV1 and HSP70 expression in bone marrow cells may be involved in visceral pain development and the analgesic effect of moxibustion on VH may be mediated through down-regulation of TRPV1 and HSP70 expression in bone marrow cells. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  MOXIBUSTION

Mesh:

Substances:

Year:  2015        PMID: 26338695     DOI: 10.1136/acupmed-2015-010788

Source DB:  PubMed          Journal:  Acupunct Med        ISSN: 0964-5284            Impact factor:   2.267


  7 in total

1.  Effects of 10.6-μm laser moxibustion and electroacupuncture at ST36 in a 5-Fu-induced diarrhea rat model.

Authors:  Huaijin Cheng; Ling Zhao; Ziyong Ju; Fan Wang; Meng Qin; Huijuan Mao; Xueyong Shen
Journal:  Support Care Cancer       Date:  2020-09-21       Impact factor: 3.603

Review 2.  Extraoral Taste Receptor Discovery: New Light on Ayurvedic Pharmacology.

Authors:  Marilena Gilca; Dorin Dragos
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-31       Impact factor: 2.629

3.  Metabolic Response in Rats following Electroacupuncture or Moxibustion Stimulation.

Authors:  Jingjing Xu; Xianwei Lin; Kian-Kai Cheng; Huan Zhong; Mi Liu; Guoshan Zhang; Guiping Shen; Jiyang Dong
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-02       Impact factor: 2.629

4.  Flutamide ameliorates uterine decidualization and angiogenesis in the mouse hyperandrogenemia model during mid-pregnancy.

Authors:  Han Gong; Weiqi Wu; Jingjie Xu; Dainan Yu; Bo Qiao; Hui Liu; Bei Yang; Yuezhen Li; Yan Ling; Haibin Kuang
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

5.  Transcriptome sequencing reveals core regulation modules and gene signatures of Zusanli acupoints in response to different moxibustion warm stimulation in adjuvant arthritis rat.

Authors:  Li Zeng; Jing Guo; Ping Du; Shuguang Yu; Haiyan Yin
Journal:  Hereditas       Date:  2022-02-22       Impact factor: 3.271

Review 6.  Moxibustion for Primary Dysmenorrhea: An Adjuvant Therapy for Pain Relief.

Authors:  Sian Pan; Shaohua Wang; Juan Li; Hanyu Yuan; Xiao Xue; Yu Liu; Zenghui Yue
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-27       Impact factor: 2.629

7.  Mast cell deficiency attenuates acupuncture analgesia for mechanical pain using c-kit gene mutant rats.

Authors:  Xiang Cui; Kun Liu; Dandan Xu; Youyou Zhang; Xun He; Hao Liu; Xinyan Gao; Bing Zhu
Journal:  J Pain Res       Date:  2018-03-05       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.